疫苗接种后流感血凝素特异性抗体的蛋白质组学分析揭示免疫球蛋白可变区特征趋同
本研究对6名接种H1N1pdm09流感疫苗受试者的抗血凝素血清抗体蛋白质组进行分析,发现2名受试者存在由IGHV5-51和IGHV3-7基因家族编码的限制性IgG1重链,4名受试者存在IGHV5-51或IGHV3-7。所有受试者均显示优势IGKV3-20轻链,5名受试者还显示IGKV3-11和IGKV4-1家族。序列与匹配的胚系序列高度一致,共享突变少。
要点
- 6名H1N1pdm09疫苗接种者中,2人IgG1重链由IGHV5-51和IGHV3-7编码,4人为IGHV5-51或IGHV3-7。
- 所有受试者优势轻链为IGKV3-20,5人还出现IGKV3-11和IGKV4-1家族。
- 抗体可变区序列与胚系序列高度一致,共享突变少,提示蛋白质组学方法可行。
核心结论
- 本研究说明利用蛋白质组学方法确定疫苗接种诱导的血清抗体可变区特征具有可行性。
研究设计与样本
- 对6名接种H1N1pdm09甲型流感疫苗受试者的抗血凝素血清抗体蛋白质组进行分析。
主要发现
- 6名受试者中,2名存在由IGHV5-51和IGHV3-7基因家族编码的限制性IgG1重链,4名存在IGHV5-51或IGHV3-7。
- 所有受试者均显示优势IGKV3-20轻链,5名受试者还显示IGKV3-11和IGKV4-1家族。
- 抗体序列与匹配的胚系序列高度一致,共享突变少。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Analysis of the anti-haemagglutinin serum antibody proteome from six H1N1pdm09 influenza A vaccinated subjects demonstrated restricted IgG1 heavy chain species encoded by IGHV5-51 and IGHV3-7 gene families in 2 subjects and either IGHV5-51 or IGHV3-7 in 4 individuals. All subjects exhibited a dominant IGKV3-20 light chain, however 5 subjects also exhibited IGKV3-11 and IGKV4-1 families. Sequences were closely aligned with the matched germline sequence, with few shared mutations. This study illustrates the feasibility of using a proteomic approach to determine the expressed V region signatures of serum antibodies induced by vaccination.
引用
- Adamson PJ, Al Kindi MA, Wang JJ, et al. Proteomic analysis of influenza haemagglutinin-specific antibodies following vaccination reveals convergent immunoglobulin variable region signatures. Vaccine. 2017. PMID: 28888340. doi:10.1016/j.vaccine.2017.08.053
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。